Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults-Reference-Cited by-同舟云学术

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults

Published:2018-03-08 Issue:1 Volume:6 Page:14
ISSN:2076-393X
Container-title:Vaccines
language:en
Short-container-title:Vaccines

Author:

Montomoli Emanuele,Torelli Alessandro,Manini Ilaria^ORCID,Gianchecchi Elena

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Link

http://www.mdpi.com/2076-393X/6/1/14/pdf

Reference98 articles.

1. Weekly Epidemiological Recordhttp://www.who.int/wer/2012/wer8747.pdf?ua=1&ua=1

2. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains;Kocik;Acta Biochim. Pol.,2014

3. Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges

4. Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009

5. Estimates of deaths associated with Seasonal Influenza—United States, 1976–2007;Morb. Mortal. Wkly. Rep.,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza season;Human Vaccines & Immunotherapeutics;2024-03-06

2. Influenza vaccine: a review on current scenario and future prospects;Journal of Genetic Engineering and Biotechnology;2023-12

3. Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea;Infectious Diseases and Therapy;2022-09-07

4. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health;Vaccine;2022-05

5. Chinese expert consensus on immunoprophylaxis of common respiratory pathogens in children (2021 edition);Journal of Thoracic Disease;2022-03